Harvard Bioscience reports $2.9M loss in Q2
HBIO Harvard Bioscience Inc
$9.09 +8.73%
View chart & analysis → - 1Harvard Bioscience (HBIO) reported a $2.9 million loss in the second quarter.
- 2The loss came to $0.64 per share, or $0.14 on a non-recurring and amortization-adjusted basis, with revenue of $22.7 million.
- 3Revenue guidance for the quarter ending September was set at a range of $21.0 million to $22.6 million.
Source Associated Press +1 · View original ↗
Nothing hidden: past picks and how they did against the S&P 500.